CRP and heart disorder: Both established markers (creatine kinase-MB (CK-MB) and C-reactive protein (CRP)) and potential future heart disease markers (D-dimer and pregnancy-associated plasma protein A (PAPP-A)) were applied in concentrations ranging from 0.25–20 μg/mL in buffer, allowing the detection of critically high protein concentrations.